Panes, Kirstin A.
HRN: 23-94-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
CEFUROXIME 750MG (VIAL)
10/23/2023
10/29/2023
IVT
195mg
Q8
Pneumonia
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes